SCHEMBL16179076

SCHEMBL16179076

[CH2]C(c1ccc(OC)cc1)N1CCCCC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P4HB P07237 2/20 0.46
POLB P06746 2/20 0.46
ALDH1A1 P00352 2/20 0.45
L3MBTL1 Q9Y468 2/20 0.45
MAPT P10636 1/20 0.45
HPGD P15428 1/20 0.45
SMAD3 P84022 1/20 0.44
HTT P42858 1/20 0.44
LMNA P02545 1/20 0.43
GRIN1 Q05586 1/20 0.42
GRIN2A Q12879 1/20 0.42
GRIN2B Q13224 1/20 0.42
P2RX7 Q99572 1/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
SLC6A2 P23975 1/20 0.42
SLC6A4 P31645 1/20 0.42
SLC6A3 Q01959 1/20 0.42
TP53 P04637 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16463712 0.83 ALDH1A1 (0.63) P4HBPOLBALDH1A1L3MBTL1MAPT
SCHEMBL16179288 0.81 HPGD (0.48) ALDH1A1L3MBTL1MAPTHPGDHTT
SCHEMBL11156973 0.80 CHRM2 (0.59) P4HBPOLBALDH1A1L3MBTL1MAPT
SCHEMBL17240261 0.79 CYP1A2 (0.46) ALDH1A1MEN1KMT2A
SCHEMBL7205156 0.79 P4HB (0.46) P4HBPOLBALDH1A1L3MBTL1MAPT
SCHEMBL24369695 0.78 CHRM2 (0.57) P4HBPOLBALDH1A1MAPTSMAD3
SCHEMBL20851520 0.78 CHRM2 (0.57) P4HBPOLBALDH1A1MAPTSMAD3
SCHEMBL19397162 0.78 CHRM2 (0.57) P4HBPOLBALDH1A1MAPTSMAD3
SCHEMBL27552081 0.76 ALDH1A1 (0.47) P4HBPOLBALDH1A1L3MBTL1MAPT
SCHEMBL9534090 0.76 CYP2D6 (0.43) ALDH1A1L3MBTL1LMNAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014170343-A1 DEPOLARIZING AGENTS AND NICOTINIC ACETYLCHOLINE RECEPTOR MODULATORS FOR TREATING DOPAMINERGIC-RELATED DISORDERS ICM (INSTITUT DU CERVEAU ET DE LA MOELLE ÉPINIÈRE) (FR) 2014-10-23 WO disclosed